This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Monkeypox Virus D13L Protein (MPXV D13L), N-His
Product Overview
BioVenic's Recombinant Monkeypox Virus D13L Protein (MPXV D13L), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 39.4 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
D13L is a critical structural protein that forms a transient hexagonal scaffold on the exterior of the developing viral membrane. This scaffold is essential for transforming flat lipid membranes into the spherical "crescent" structures required for Intracellular Mature Virus (IMV) assembly. As the major target of the antiviral drug Rifampicin, D13L is indispensable for viral morphogenesis. Without functional D13L, the virus cannot form infectious progeny. Its unique structural role makes it a high-priority target for small-molecule inhibitors and structural studies focusing on poxvirus maturation.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
